Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-11-14

FDA Approved: NITROFURANTOIN (MACROCRYSTALS) — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Nitrofurantoin (Macrocrystals) from Aurobindo Pharma Limited, enabling continued marketing under updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (Macrocrystals) (Nitrofurantoin)

Snippet

SUPPL AP for NITROFURANTOIN (MACROCRYSTALS) (NITROFURANTOIN (MACROCRYSTALS))